Answers are grounded in this paper and cite their sources.
Analysis shows liver injury risks in antibiotics erythromycin and oleandomycin, indicating their broad spectrum label is misleading.
Erythromycin estolate (Ilosone - Lilly) and triacetyloleandomycin (Evramycin - Wyeth) can cause liver injury and a re-evaluation of these antibiotics is necessary. Both are sometimes termed “broad spectrum” but this is an error, for they have essentially the same antibacterial spectrum as penicillin, and resemble one another in many respects.
No takes yet. Share an insight, caveat, or question.
A 1962 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: